The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.
CITATION STYLE
Stienlauf, S., Yahalom, V., Schwartz, E., Shinar, E., Segal, G., & Sidi, Y. (2009). Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel. Emerging Infectious Diseases, 15(7), 1116–1118. https://doi.org/10.3201/eid1507.080796
Mendeley helps you to discover research relevant for your work.